Edition:
United States

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

76.48USD
4:00pm EDT
Change (% chg)

$-4.27 (-5.29%)
Prev Close
$80.75
Open
$79.27
Day's High
$80.44
Day's Low
$75.15
Volume
161,797
Avg. Vol
139,824
52-wk High
$134.00
52-wk Low
$20.12

Chart for

About

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)

Overall

Beta: --
Market Cap(Mil.): $1,768.20
Shares Outstanding(Mil.): 23.50
Dividend: --
Yield (%): --

Financials

  ANAB.OQ Industry Sector
P/E (TTM): -- 241.68 34.14
EPS (TTM): -1.18 -- --
ROI: -12.34 -5.91 13.17
ROE: -12.91 -7.75 15.14

BRIEF-Anaptysbio Qtrly Loss Per Share $0.63

* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATES

May 08 2018

BRIEF-Anaptysbio Announces Positive Top-Line Proof-Of-Concept Data For ANB020 In Moderate-To-Severe Baseline Adult Peanut Allergy Patients

* ANAPTYSBIO ANNOUNCES POSITIVE TOP-LINE PROOF-OF-CONCEPT DATA FOR ANB020 IN MODERATE-TO-SEVERE BASELINE ADULT PEANUT ALLERGY PATIENTS

Mar 26 2018

BRIEF-AnaptysBio Qtrly ‍Loss Per Share $0.30

* ANAPTYSBIO ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND 2018 PIPELINE MILESTONES

Mar 05 2018

Earnings vs. Estimates